Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1Phase 1/2 1

Status

Active not recruiting 2Terminated 1Completed 1

Sponsor Class

OTHER 3INDUSTRY 1

Study Type

Interventional 3Observational 1

Sponsor

Cancer Type

Breast 2Gastrointestinal 1CNS 1

Conditions

Rectal Neoplasms 1Glioblastoma 1Breast Neoplasms 1Brain Neoplasms 1Advanced Breast Cancer 1

Interventions

Specimen Handling 641pembrolizumab 585Magnetic Resonance Spectroscopy 555Carboplatin 431Cyclophosphamide 381Cisplatin 379Biopsy 376Nivolumab 315Paclitaxel 314Gemcitabine 308Radiotherapy 286Bevacizumab 235Dexamethasone 218fludarabine 206Docetaxel 194durvalumab 189Oxaliplatin 189venetoclax 187Rituximab 175Fluorouracil 175atezolizumab 172Pemetrexed 167Capecitabine 164Radiosurgery 162Doxorubicin 162Radiation 160Ipilimumab 146Lenalidomide 140Leucovorin 138Etoposide 134

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Lead × 90 days × Clear all
NCT05085002 2026-05-14

A Study of Lerociclib in Participants With Advanced Breast Cancer

EQRx International, Inc.

Phase 2 Terminated
100 enrolled 14 charts
Breast

Advanced Breast Cancer

NCT01517945 2026-04-24

Attention and Interpretation Modification (AIM) for Fear of Cancer Recurrence: An Intervention Development Study

Memorial Sloan Kettering Cancer Center

Active not recruiting
252 enrolled
Breast

Breast Neoplasms

NCT03277638 2026-04-09

Laser Interstitial Thermotherapy (LITT) Combined With Checkpoint Inhibitor for Recurrent GBM (RGBM)

Case Comprehensive Cancer Center

Phase 1/2 Active not recruiting
32 enrolled
CNS

Brain Neoplasms, Glioblastoma

NCT03292289 2026-03-17

QUALIPRO

Centre Oscar Lambret

Phase NA Completed
65 enrolled
Gastrointestinal

Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡